Recombinant Lamin A/C (LMNA) Homo sapiens (Human) Recombinant protein

CDCD1; CMD1A; CMT2B1; EMD2; FPL; FPLD; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; PRO1; Cardiomyopathy Dilated 1A; Limb Girdle Muscular Dystrophy 1B; Progeria 1

  • Product No.RPF550Hu01
  • Organism SpeciesHomo sapiens (Human)
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular Locationn/a
  • Predicted Molecular Mass52.2kDa
  • Accurate Molecular Massn/a(Analysis of differences refer to the manual)
  • Residues & TagsMet1~Glu422 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Pointn/a
  • ApplicationsSDS-PAGE; WB; ELISA; IP.
  • DownloadInstruction Manual
  • UOM 10ug50ug 250ug 1mg 1g
  • FOB US$ 184US$ 460 US$ 1150 US$ 2760 US$ 69000
  • Recombinant Lamin A/C (LMNA) Package and Components
  • Recombinant Lamin A/C (LMNA) Package and Components
  • RPF550Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE

USAGE

Reconstitute in PBS or others.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Reference

  • Clin Cancer ResInactivation of the p53–KLF9–CEBPA Axis in Acute Myeloid LeukemiaPubMed: 26408402